Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphomaPrakash Satwani, Mitchell S. Cairo, James H. Garvin et al.|Leukemia|2014Cited by 53
Sequential Myeloablative Autologous Stem Cell Transplantation and Reduced Intensity Allogeneic Stem Cell Transplantation in Children, Adolescents and Young Adults with Poor Risk Refractory or Recurrent Hodgkin (HL) and Non-Hodgkin Lymphoma (NHL)Prakash Satwani, Mitchell S. Cairo, Zhezhen Jin et al.|Transplantation and Cellular Therapy|2014Cited by 1